GlassScriptPhysician profile
Roy I Schwartz
NPI 1649352394
$9,317.99
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,035 · 2021: $242 · 2022: $6,688 · 2023: $144 · 2024: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,682.71 | 2022-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,163.18 | 2019 | |
| Asensus Surgical, INC. | $667.42 | 2019 | |
| Reshape Lifesciences INC. | $374.16 | 2019-2023 | |
| Davol INC. | $162.70 | 2021-2024 | Phasix Mesh |
| Redhill Biopharma INC. | $88.20 | 2021 | |
| Medtronic, INC. | $48.33 | 2024 | Symbotex |
| Ethicon US, LLC | $34.29 | 2023 | Echelon Flex |
| Focal Therapeutics, INC. | $22.15 | 2019 | |
| Novo Nordisk INC | $19.44 | 2023 | Wegovy |
| Kerecis Limited | $15.22 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $14.72 | 2022 | |
| Hologic Sales and Service, LLC | $14.51 | 2023 | Localizer, Trident Specimen Radiography System |
| Acell, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.